Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Autistic Disorder: early-phase trial registry
5 of 28 indexed Autistic Disorder trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #577 of 28,707 conditions by registered trial count.
28 US clinical trials · 5 currently recruiting · #577 of 28,707 conditions by registered trial count
Autistic Disorder: 28 US clinical trials tracked, 5 recruiting.
Autistic Disorder is the subject of 28 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is Stanford University, running 3 of these trials.
Enrollment posture brief
Registry condition autistic-disorder
OPEN 5 | RECR 18% | LATE 4 | EARLY 7 | RANK #577 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Macular Degeneration (18% recruiting · 28 trials)
Autistic Disorder lists 5 open slots (18% of 28 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Autistic Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Autistic Disorder is recruiting below its size-band peers.
5 of 28 indexed trials (17.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Autistic Disorder trials is spread across many organizations.
Stanford University accounts for 3 of 28 trials (10.7%). 21 distinct sponsors appear on at least one study for this condition label.
-
Most Autistic Disorder trials plan to enrol fewer than 100 people.
Median target enrolment is 68 among the 28 trials that report a genuine target (sentinel values excluded). 19 of those (67.9%) plan for fewer than 100 participants.
-
Autistic Disorder research is mostly interventional.
24 interventional and 4 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
28 total, page 1 of 1
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
Ball State University
NCT06309160
Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)
Hugo W. Moser Research Institute at Kennedy Krieger
NCT05176808
Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders
Children's Hospital Medical Center, Cincinnati
NCT06227780
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
American Federation of Medical Synergetics
NCT03222375
Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum Disorder
University of Pennsylvania
NCT06859918
Project AFECT (Autism Family Empowerment Coaching and Training Program)
Stanford University
NCT05910502
Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism
Rutgers, The State University of New Jersey
NCT02677051
Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine
Forest Laboratories
NCT01592747
Exome Sequencing in Autistic Spectrum Disorder
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NCT01059201
Study of Fluoxetine in Autism
Neuropharm
NCT00515320
Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)
Boston University
NCT00086645
A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD
Wave Neuroscience
NCT02758496
A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
NCT00576732
Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder
University of Pittsburgh
NCT03170453
Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
Indiana University
NCT00198107
D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
Indiana University
NCT01086475
Trial of Methyl B12 on Behavioral and Metabolic Measures in Children With Autism
University of California, San Francisco
NCT01039792
An Exploratory, Double-Blind, Placebo-Controlled Study of the Medical Food Vayarin in Children With Autism Spectrum Disorder (ASD)
Enzymotec
NCT02222285
Pivotal Response Group Treatment for Parents of Young Children With Autism
Stanford University
NCT01881750
An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism
Stanford University
NCT01400269
Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders
University of Pennsylvania
NCT04788537
An Evaluation of Low Level Laser Light Therapy for Autistic Disorder 2
Erchonia Corporation
NCT04895605
Study of Acamprosate in Autism
Children's Hospital Medical Center, Cincinnati
NCT01813318
Donepezil HCl & Cognitive Deficits in Autism
University of Pittsburgh
NCT00047697
A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders
Indiana University School of Medicine
NCT00453180
Training Attention and Eye Movement in ASD
University of California, San Diego
NCT02403817
Building Social Skills With Interdisciplinary Process Drama in ASD
University of Utah
NCT03536351
A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT
Wave Neuroscience
NCT02746445
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 6 |
| Phase 3 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Autistic Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Autistic Disorder trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Autistic Disorder page
28 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Autistic Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Stanford University sponsors the most Autistic Disorder trials on record, review their full trial history before evaluating a specific study. See Stanford University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Autistic Disorder condition card totals 28 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.